Health technology assessment (HTA) is an evaluation of health technologies in terms of facts and evidence. However, the relationship between facts and values is still not clear in HTA. This is problematic in an era of "fake facts" and "truth production." Accordingly, the objective of this study is to clarify the relationship between facts and values in HTA. We start with the perspectives of the traditional positivist account of "evaluating facts" and the social-constructivist account of "facting values." Our analysis reveals diverse relationships between facts and a spectrum of values, ranging from basic human values, to the values of health professionals, and values of and in HTA, as well as for decision making.
| INTRODUCTION
In all types of evaluations and assessments, the fact-value distinction is of crucial interest, [1] [2] [3] so also in health technology assessment (HTA), which conveys between facts and values on several levels. First, HTA includes the assessment of ethical, social, legal, and cultural aspects, as expressed in many of its definitions, which are clearly value related. [4] [5] [6] Ignoring social values in assessing facts may render HTA analysis contentious or of questionable relevance, as illustrated by cases, such as prenatal screening, breast cancer screening, or cochlear implants, where social values have diverted from the outcomes valued by HTA. Second, there are many levels of values at play in the HTA process itself, for example, in the selection of end points and economic models. [7] [8] [9] [10] Accordingly, value assessment frameworks, such as multi-criteria decision analysis (MCDA), have been developed for HTA. 11, 12 Third, increased stakeholder involvement (with different value perspectives)
on all levels contributes in forming and framing the fact-value relationship. Fourth, policy and decision-making level settings increasingly come to play on the information gathering and review level of HTA, potentially influencing the production (and framing) of facts. For instance, strong stakeholder groups and media attention may influence how different aspects are investigated, assessed, and presented. Additionally (fifth), a wide range of (epistemic and nonepistemic) values are in play in the outcomes research that form the input to and foundation of systematic reviews. [13] [14] [15] All in all, this makes what is considered to be putatively factual evidence, value laden.
These fact-value interactions are interesting in their own right but become ever more pressing in the so-called postfactual times, ie, times when the truth status of traditional fact producing and conveying institutions are questioned. Even though HTA can refer to a tradition of systematic, rigid, and transparent methodology, the issue of fact production in HTA becomes important in times of plentiful "fake facts." A thorough analysis of the fact-value relationship in HTA becomes more important than ever in order to maintain trust in HTA-with regard to both its process and its results. Even more, attending to this relationship can help ensure that policy decisions are both respectful and reflective of the values and preferences of those affected by the decision, thereby improving the likelihood that stakeholders will accept and commit to decisions based on it.
In this situation, HTA manoeuvres between 2 extremes: gathering and evaluating neutral facts on the one hand (the traditional positivist account) and "facting values" (the social-constructivist account) on the other. However, HTA does neither only assess existing value neutral facts (on the one hand) nor produce purely value-based facts (on the other). It evaluates facts that are produced because they are considered valuable. Accordingly, the objective in this article is to address where HTA can manoeuvre in this landscape. In particular, we investigate the role of philosophy and the importance of sticking to the goals of HTA.
| EVALUATING FACTS
According to what may be classified as a traditional positivist account, facts are given by observation of nature. Facts are objective and independent of observer and the observed. Whether a person is dead (eg, from acute myocardial infarction) is a fact in that can be verified by any reasonably skilled person. The relevance and importance of such facts are value issues, which are separate from the facts. It is a fact that colorectal cancer (CRC) screening with sigmoidoscopy reduces CRCrelated mortality with 27% in Norway. 16 However, which consequences this should have for a CRC screening programme is an issue of value (and currently of significant debate). Correspondingly, the selection of mortality as the most relevant outcome with which to assess the effectiveness of CRC screening is also the result of a series of value judgements.
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Health technology assessment has traditionally been based on such a distinction between facts and values. The gathering, systematizing, and synthesizing of information has been considered as the factual (assessment) part and the appraisal of this information as part of or preparing a decision-making process has been considered to be an issue of value (evaluation). To some extent, such a view is based on the conception that technology is value neutral. 18 This distinction between facts and values is explicit within HTA in processes where facts and values are considered to be collected and analysed separately from one another and "integrated" through an appraisal process, for example, deliberation. In such processes, value judgements are considered to enter into HTA only at the point of recommendation development, when value judgements are made about the results of the various assessment domains. Against this traditional (and tenacious) conception, it has been argued that the fact-value distinction is difficult to maintain. From a philosophical perspective, it has been argued that how we see facts strongly depends on our preconceptions and our value system. [20] [21] [22] Whether
Distinction between facts and values in the health technology assessment process one sees a person's fatigue as a postviral reaction or as a behavioural (or psychological) condition, does not only depend on observations in nature. How we define death strongly depends on our social commitments (eg, prospective organ transplantation, respect for relatives) and on technology (brain angiogram, magnetic resonance imaging).
In manoeuvring between these 2 extremes in practice, HTA producers and users have implicitly, and sometimes explicitly, imported a view related to the traditional positivist account, and found traditionally in debates about the distinction between science and technology or between pure and applied science. This view is called "the myth of purity." 23 When imported to HTA, it holds that at least some domains of an HTA are "pure." One manifestation of this view is a distinction between "context-free" and "context-sensitive" evidence. 19 We are not implying that evidence cannot be of different kinds, rather our point is that some draw from this difference the (we think, incorrect) conclusion that some facts gathered for HTA are strongly influenced by value judgements or values, while others are not. The results of a randomized controlled trial provide "context-free evidence" while cost-effectiveness analyses provide "context-sensitive evidence." These and similar construals of the facts collected for HTA are perhaps the result of a focus on an insufficiently theorized notion of "objectivity" and a "continuum of objectivity" is a sensible and reasonable way to think about the relation between facts and values. For example, it is stated that Ontario
Health Technology Advisory Committee in Canada "relies on reviews that systematically appraise the available evidence in a scientifically sound and objective manner." 24 Common assessment and appraisal frameworks, such as Grading of Recommendations Assessment, Development and Evaluation, also adopt the "additive" approach displayed in Figure 1 (in which facts and values are "added" together between analysis and decision-making stages) and hence also reflect an assumption about the neat separation between facts and values. 25 An exception to the HTA processes that make this traditional assumption is arguably National Institute for Health and Clin- As a result of this, the HTA community itself has developed and applied a variety of value assessment frameworks, such as multi-criteria decision analysis. 11, 12 Other approaches, such as accountability for reasonableness framework, 34 are procedural but still involve substantive moral judgements. 35 There are also combinations of various frameworks. 29 They try to include value issues in an open, transparent, and dynamic manner and thereby address some of the critique of value neglect in HTA.
| FACTING EVALUATIONS
However, some would argue that this may not be radical enough.
Including and adding value aspects to factual information is not sufficient. The values of various health technologies are not revealed or discovered but are shaped, constructed, or (re)negotiated. 36 Whether we see obesity as a disease, a risk factor, or a controlling and stigmatizing categorization of human bodies strongly depends on our perspective and our goal.
This way of accounting for values in the assessment of technologies is associated with Science and Technology Studies
(STS), where the fact-value distinction is rejected altogether.
3,37,38
Seeing something as a fact is already to make an evaluation. Science and Technology Studies contrasts traditional humanist analysis, which conceives technology as something given (black box) where the main objective is to scrutinize its relations to metaphysics, 39 the human condition, 40 human culture, 41 morality, 42 politics, 43 and the structure of society. 44 It studies how social, political, and cultural values affect scientific research and technological innovation and how these in turn affect society, politics, and culture. In particular, it investigates how technology influences people's perception of the world and human behaviour (in so-called scripts). [45] [46] [47] [48] [49] The strong influence of technology on society is sometimes analysed in terms of technology having some kind of moral agency. Core Model was an early attempt to do something similar by framing the entire HTA against answers to a series of morally relevant questions. 56 While this was done explicitly to safeguard against unethical use of technologies and to provide information about how they can instead be used in a beneficial way, the authors advocated that every HTA process should be performed with consideration paid to 8 ethical issues:
1. The driving forces (and valued interests) behind the plan to perform the assessment at this particular stage should be identified, including the stakeholders and the whole HTA organization.
The morally relevant reasons for performing/not performing an
HTA on the topic should be identified.
3. The interests of the technology producers should be identified.
4. Possible related technologies that are morally contentious should be identified.
5. The interests of the content expert group should be discussed openly in order for the work to be conducted in an objective and independent way.
6. The choice of end points in the assessment has to be carefully considered.
7. The morally relevant issues related to the selection of meta-analyses and studies the HTA means to include must be identified.
8. The scope of the HTA and the choice of research methods (eg, inclusion of other assessment aspects than effectiveness in the literature searches).
Nevertheless, the practical question of how this might be done and how it could facilitate discussion within a traditional HTA process remains.
One alternative for addressing the fact-value relationship is to scrutinize how technology enables and constrains certain human actions and goals. 57, 58 This makes it possible to address the value ladenness of technology without claiming moral agency for technological artefacts. It has also been suggested to pay attention to value judgements in evidence production with respect to (1) choosing outcome measures, (2) balancing benefits and harms, and (3) tolerating uncertainty. 10 Other value judgements have been added elsewhere 8, 9 , and Figure 2 sums up a broader range of value issues.
Another approach can be to apply the framework from Responsible
Research and Innovation, with emphasis on anticipation of the application of technology, reflexivity on the innovation, inclusion of relevant voices, and responsiveness to emergent events. 59 
| GOALS OF HTA
Values come into HTA with goals and its methods (through function).
The overall goals of HTA coincide with the goals of medicine and health care (ie, to reduce suffering and improve the health of individuals in a society). 71, 72 However, the goals of medicine and health care are diverse. In the narrow sense, the objective is to cure or prevent disease, as well as palliate and postpone (where cure is not possible). In a wider sense, the goal is to promote health and well-being. In an even wider sense (policy level), it is "to make the system work." The fact-value relationship may differ with these goals, in the sense that different goals give rise to the need for answering different factual questions. For example, the facts may support that something is a good health intervention on the level of specific patients but not support that it is so on a societal level or from a systems perspective and conversely.
Recent examples of this are orphan drugs that might be effective but not cost-effective and due to high cost, a strain to the system. 73 There have been several attempts to clarify the goals of and in health care. 71, 72 Because of expansions of medicine and health care beyond treating disease and promoting health, eg, towards various forms of human enhancement, 74 this has not been an easy task. Nonetheless, it is possible to give an outline of various values involved in HTA, eg, as given in Figure 2 • Publicity-that the reasons for the decisions should be publicly available.
• Relevance-that the reasons for priority setting should be regarded as reasonable and be accepted as relevant by fair-minded people with the ambition to find common ground for cooperation.
• Revision and appeals-that there should be opportunity to appeal for decisions and in light of new evidence and argument revise decisions.
• Regulative-that there should be some form of process to enforce decisions made.
Correspondingly, the facts relate to a more specific range of values (and thus be easier to define, identify, and delineate) in appraisal than in decision making. Assessment of facts connected to values such as survival, nonmorbidity, and safety-the so-called hard outcomes-is easier to define. 4. To address conceptual issues of normative importance, as some concepts are strongly value laden.
5. To promote reflection on HTA's own value system in doing HTA.
We have also pointed out that the goals (ie, the values) may differ on various levels of the health-care system (including HTA and policymaking) and that this may result in (hidden) value conflicts and a variety of fact-value relationships. to analyse evaluative argumentation relating to presented facts about technologies; to address conceptual issues of normative importance, as some concepts are strongly value laden; and to promote reflection on HTA's own value system in doing HTAs.
Health technology assessment is unique in bringing together facts and values, and being conscious and explicit about this "factuation" is key to making HTA valuable to health policy decision makers and the health systems and societies that rely on them.
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